Atlantic Edge Private Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Atlantic Edge Private Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.08K	Hold	193	–	–	﹤0.01%	433
2026 Q1	$3.65K	Hold	193	–	–	﹤0.01%	489
2025 Q4	$2.58K	Hold	193	–	–	﹤0.01%	508
2025 Q3	$2.28K	Hold	193	–	–	﹤0.01%	492
2025 Q2	$1.25K	Hold	193	–	–	﹤0.01%	485
2025 Q1	$1.13K	Buy	+193	New	+$1.38K	﹤0.01%	474

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Atlantic Edge Private Wealth Management's DFTX Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 193 shares worth $9.08K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Atlantic Edge Private Wealth Management first reported a position in DFTX in Q1 2025 and has held it in 6 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Atlantic Edge Private Wealth Management held 193 shares of Definium Therapeutics worth $9.08K as of Q2 2026.
Atlantic Edge Private Wealth Management left its Definium Therapeutics share count unchanged in Q2 2026.
Definium Therapeutics made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #433 holding.
Atlantic Edge Private Wealth Management first reported a position in Definium Therapeutics in Q1 2025 and has held it in 6 quarters since.
361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.